Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
6
86%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
6(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Other(3)

Detailed Status

unknown3
Completed3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 46 (100.0%)

Trials by Status

unknown343%
completed343%
enrolling_by_invitation114%

Recent Activity

0 active trials
Showing 5 of 7
enrolling_by_invitationphase_4

An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

NCT06484686
unknownphase_4

Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus

NCT05460429
unknownphase_4

Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province

NCT05470855
completed

Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

NCT02983656
unknownphase_4

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

NCT01982409
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06484686Phase 4

An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

Enrolling By Invitation
NCT05460429Phase 4

Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus

Unknown
NCT05470855Phase 4

Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province

Unknown
NCT02983656

Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

Completed
NCT01982409Phase 4

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

Unknown
NCT01815073Phase 4

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Completed
NCT01817270Phase 4

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7